comparemela.com

Latest Breaking News On - James lanthier - Page 9 : comparemela.com

NA Proactive news snapshot: Nano One Materials Corp, Gander Gold Corporation, Todos Medical Ltd, Gratomic Inc, PlantX Life Inc, KULR Technology Group Inc, World Copper Ltd, Outlook Therapeutics Inc, CleanSpark Inc, Plurilock Security Inc, Majuba Hill Copp

Nano One Materials Corp (TSX:NANO, OTC:NNOMF) and Euro Manganese Inc (ASX:EMN, TSX-V:EMN, OTCQX:EUMNF) announced positive news in their joint development.

Capim grossoUnited statesDios padreHong kongUnited kingdomBritish columbiaWashington universityPershing countyHawk ridgePumpkin hollowFrank carnevaleNolan petersonRandy buffingtonMancha amarillaMartin lehrJames lanthier

Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of Phase 1 First-In-Human Clinical Trial Plan for Its Lead Clinical Candidate, MSP-1014

Mindset Pharma Receives Scientific Advice from UK Regulator Facilitating Advancement of Phase 1 First-In-Human Clinical Trial Plan for Its Lead Clinical Candidate, MSP-1014 - read this article along with other careers information, tips and advice on BioSpace

United kingdomJason atkinsonJames lanthierMckenna millerAllison sossOtsuka pharmaceuticalsUnited contract research organizationCompany contactStrategic researchRegulatory agencyMcquade centerStrategic communicationsMindset pharma incCorporate developmentClerkenwell healthScientific advice

Mindset Pharma Receives Scientific Advice from UK Regulator

TORONTO, Sept. 14, 2022 (GLOBE NEWSWIRE) Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery.

United kingdomJason atkinsonJames lanthierMckenna millerAllison sossOtsuka pharmaceuticalsUnited contract research organizationCompany contactStrategic researchRegulatory agencyMcquade centerStrategic communicationsMindset pharma incClerkenwell healthScientific adviceUnited kingdom medicines

Mindset Pharma Inc files 16 national patent applications to protect family of novel next-generation psychedelics

Mindset Pharma Inc files 16 national patent applications to protect family of novel next-generation psychedelics
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesJames lanthierTrademark officeMindset pharma incSouth east asianUnited states patent

Mindset Pharma Inc adds to IP portfolio with three non-tryptamine families of next-gen psychedelic compounds

Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) CEO James Lanthier and chief scientific officer Joseph Araujo joined Proactive s Stephen Gunnion.

Joseph araujoStephen gunnionJames lanthierMindset pharma inc

vimarsana © 2020. All Rights Reserved.